State Street
ENFN

State Street’s Enfusion, Inc. ENFN Stock Holding History

State Street’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,425,934
Closed -$15.9M – 4341
2025
Q1 		$15.9M Buy
1,425,934
+94,838
+7% +$1.05M ﹤0.01% 2262
2024
Q4 		$13.7M Buy
1,331,096
+378,201
+40% +$3.66M ﹤0.01% 2437
2024
Q3 		$9.04M Buy
952,895
+21,729
+2% +$187K ﹤0.01% 2668
2024
Q2 		$7.93M Buy
931,166
+175,464
+23% +$1.61M ﹤0.01% 2701
2024
Q1 		$6.99M Buy
755,702
+64,084
+9% +$564K ﹤0.01% 2776
2023
Q4 		$6.71M Buy
691,618
+108,166
+19% +$1.01M ﹤0.01% 2796
2023
Q3 		$5.23M Buy
583,452
+48,339
+9% +$459K ﹤0.01% 2893
2023
Q2 		$6M Buy
535,113
+12,312
+2% +$109K ﹤0.01% 2909
2023
Q1 		$5.49M Sell
522,801
-6,623
-1% -$73K ﹤0.01% 2960
2022
Q4 		$5.12M Buy
529,424
+3,787
+0.7% +$42.6K ﹤0.01% 3030
2022
Q3 		$6.49M Buy
525,637
+31,465
+6% +$384K ﹤0.01% 2931
2022
Q2 		$5.04M Buy
494,172
+150,179
+44% +$1.66M ﹤0.01% 3099
2022
Q1 		$4.38M Buy
343,993
+84,588
+33% +$1.29M ﹤0.01% 3250
2021
Q4 		$5.43M Buy
+259,405
New +$5.24M ﹤0.01% 3199

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State Street's ENFN Position: Q2 2025 in Review

State Street sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 1,425,934 shares — an estimated $15.9M sold.

State Street first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $15.9M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • State Street reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • State Street sold 1,425,934 Enfusion, Inc. shares in Q2 2025, an estimated $15.9M.
  • State Street first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • State Street's Enfusion, Inc. position peaked at $15.9M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.